THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

City cuts back on plan to regulate biolabs

Scientists feared loss of confidentiality

By Stephen Heuser
Globe Staff / August 23, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In the face of opposition from Harvard University, pharmaceutical giant Merck & Co., and the state biotechnology industry, Boston is scaling back its pioneering plan to regulate research on infectious organisms in laboratories within city limits. (Full article: 1172 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass